Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

Loading...
Assessment of Effectiveness and Impact of Universal Prophylaxis With Nirsevimab for Prevention of Hospitalizations Due to Respiratory Syncytial Virus in Infants. The NIRSE-GAL Study Protocol
2024 · Instituto de Investigación Sanitaria, · World Health Organization (WHO), · University of Santiago de Compostela, · Instituto de Salud Carlos III
The NIRSE-GAL study in Galicia, Spain, aims to assess the effectiveness of nirsevimab in preventing hospitalizations due to Respiratory Syncytial Virus (RSV) in infants. It …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Evaluation of Antibody-Based Preventive Alternatives for Respiratory Syncytial Virus: A Novel Multi-Criteria Decision Analysis Framework and Assessment of Nirsevimab in Spain
2024 · University Carlos III, · BioMad, · Fisabio-Public Health, · Catholic University of Valencia, · Instituto de Salud Carlos III, · Weber Foundation
This study evaluates nirsevimab, an antibody-based preventive measure for respiratory syncytial virus (RSV) in Spain. Using a multi-criteria decision analysis framework, experts found that nirsevimab …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
2024 · Fisabio-Public Health, · Instituto de Salud Carlos III, · University of Valencia
This study in Spain evaluated nirsevimab's efficacy in preventing respiratory syncytial virus (RSV) infections in infants under ten months. The immunization campaign targeted all infants …
  • Access Journal ArticleEN
  • Ask aRCie Ask aRCie

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie